Cite
MLA Citation
Heather L. Platt et al.. “A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).” Vaccine, vol. 40, no. 1, 2022, pp. 162–172. http://access.bl.uk/ark:/81055/vdc_100146760239.0x000046